射频消融治疗肝脏良性占位性病变的现状及进展  

Current situation and progression of radiofrequency ablation therapy for benign space occupying lesion of the liver

作　　者：杜英瑞 柯山[1] 高君[1] 丁雪梅[1] 王劭宏[1] 孔健[1] 孙文兵[1] Du Yingrui;Ke Shah;Gao Jun;Ding Xuemei;Wang Shao- hong;Kong Jian;Sun Wenbing.(Department of Hepatobiliary Surgery, Beijing Chao Yang Hospital Affiliated to Capital Medical University, Beifing 100043, China)

机构地区：[1]首都医科大学附属北京朝阳医院肝胆外科,100043

出　　处：《中华肝胆外科杂志》2018年第4期283-286,共4页Chinese Journal of Hepatobiliary Surgery

基　　金：国家自然科学基金（81572957;81502650）;北京市石景山区医学重点学科建设项目（20130001）;北京市医管局培育计划项目（PX2017014）

摘　　要：肝脏良性占位性病变（BOL）是发生于肝脏的具有占位效应的良性病变，部分需要积极治疗。已有文献报道将射频消融（RFA）用于治疗肝血管瘤、肝局灶性结节性增生、肝腺瘤、肝囊肿、肝脓肿和肝包虫病等BOL。RFA治疗肝血管瘤有取代外科切除成为首选治疗方案的趋势；对于复杂、难治的肝囊肿、肝脓肿，如患者不愿手术或难以耐受手术，RFA可作为外科手术的替代选择。RFA在肝局灶性结节性增生、肝腺瘤、肝包虫的治疗中也表现出了安全、微创、疗效确切及可重复操作的优势。本文就RFA治疗BOL的现状及进展做一综述。Benign occupations of the liver （BOL） are a heterogeneous group of benign hepatic lesions, a minority of which may need active management. It＇s reported that radiofre- quency ablation （RFA） can be used to treat BOL, such as hepatic haemangioma, focal nodular hyperplasia （FNH） , hepato- cellular adenoma, simple hepatic cyst, liver abscess and hepatic echinococcosis. RFA has exhibited a potentiality to replace re- section as the first-line treatment option for hepatic haemangio- ma. For muhiloculated intractable simple hepatic cyst or liver abscess, when patients are not suitable for or refuse surgical resection, RFA may be an alternative option for the resection; and it also has many advantages over resection, including effectiveness, safety, minimal invasiveness and repeatability in the treatment of FNH, hepatocellular adenoma, and hepatic echinoeoc- eosis. A review will be presented on the current situation and latest progression of RFA therapy for BOL in this article.

关 键 词：肝脏良性占位性病变 射频消融 疗效 

分 类 号：R735.7[医药卫生—肿瘤]